Oncternal Therapeutics, Inc. announced the appointment of Pablo Urbaneja as Senior Vice President, Corporate Development. Mr. Urbaneja will be responsible for strategic planning and advancing corporate and business development initiatives at Oncternal. Most recently he served as Vice President, Corporate Development at Coherus Biosciences, where he helped transform its biosimilars and immuno-oncology late-stage pipeline.